148 related articles for article (PubMed ID: 8883829)
1. Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration.
Neckelmann D; Bjorvatn B; Bjørkum AA; Ursin R
Behav Brain Res; 1996 Sep; 79(1-2):183-92. PubMed ID: 8883829
[TBL] [Abstract][Full Text] [Related]
2. Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram.
Neckelmann D; Bjørkum AA; Bjorvatn B; Ursin R
Behav Brain Res; 1996 Feb; 75(1-2):159-68. PubMed ID: 8800653
[TBL] [Abstract][Full Text] [Related]
3. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
Bjorvatn B; Bjørkum AA; Neckelmann D; Ursin R
Sleep; 1995 Jul; 18(6):451-62. PubMed ID: 7481417
[TBL] [Abstract][Full Text] [Related]
4. Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment.
Vas S; Kátai Z; Kostyalik D; Pap D; Molnár E; Petschner P; Kalmár L; Bagdy G
J Neural Transm (Vienna); 2013 Jan; 120(1):169-76. PubMed ID: 22729519
[TBL] [Abstract][Full Text] [Related]
5. Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains.
Kostyalik D; Vas S; Kátai Z; Kitka T; Gyertyán I; Bagdy G; Tóthfalusi L
BMC Neurosci; 2014 Nov; 15():120. PubMed ID: 25406958
[TBL] [Abstract][Full Text] [Related]
6. Sleep-wake and eeg effects following adenosine a1 agonism and antagonism: similarities and interactions with sleep-wake and eeg effects following a serotonin reuptake inhibitor in rats.
Ursin R; Bjorvatn B
Sleep Res Online; 1998; 1(3):119-27. PubMed ID: 11382868
[TBL] [Abstract][Full Text] [Related]
7. Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.
Kostyalik D; Kátai Z; Vas S; Pap D; Petschner P; Molnár E; Gyertyán I; Kalmár L; Tóthfalusi L; Bagdy G
Exp Brain Res; 2014 Mar; 232(3):935-46. PubMed ID: 24395141
[TBL] [Abstract][Full Text] [Related]
8. Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat.
Cespuglio R; Rousset C; Debilly G; Rochat C; Millan MJ
Psychopharmacology (Berl); 2005 Oct; 181(4):639-52. PubMed ID: 15983796
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH
Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic escitalopram alter EEG gamma oscillations differently: relevance to therapeutic effects.
Papp N; Vas S; Bogáthy E; Kátai Z; Kostyalik D; Bagdy G
Eur J Pharm Sci; 2018 Aug; 121():347-355. PubMed ID: 29908300
[TBL] [Abstract][Full Text] [Related]
11. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats.
Sommerfelt L; Ursin R
Behav Brain Res; 1991 Nov; 45(2):105-15. PubMed ID: 1838688
[TBL] [Abstract][Full Text] [Related]
12. Effects of citalopram on jaw-closing muscle activity during sleep and wakefulness in mice.
Ikawa Y; Mochizuki A; Katayama K; Kato T; Ikeda M; Abe Y; Nakamura S; Nakayama K; Wakabayashi N; Baba K; Inoue T
Neurosci Res; 2016 Dec; 113():48-55. PubMed ID: 27453206
[TBL] [Abstract][Full Text] [Related]
13. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.
Nishino S; Mao J; Sampathkumaran R; Shelton J
Sleep Res Online; 1998; 1(1):49-61. PubMed ID: 11382857
[TBL] [Abstract][Full Text] [Related]
14. Different effects of phenelzine treatment on EEG topography in waking and sleep in depressed patients.
Landolt HP; Gillin JC
Neuropsychopharmacology; 2002 Sep; 27(3):462-9. PubMed ID: 12225703
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and chronic treatment with trazodone, an antidepressant, on the sleep-wake activity in rats.
Lelkes Z; Obál F; Alföldi P; Erdös A; Rubicsek G; Benedek G
Pharmacol Res; 1994; 30(2):105-15. PubMed ID: 7816739
[TBL] [Abstract][Full Text] [Related]
16. The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat.
Feinberg I; Campbell IG; Schoepp DD; Anderson K
Pharmacol Biochem Behav; 2002 Sep; 73(2):467-74. PubMed ID: 12117602
[TBL] [Abstract][Full Text] [Related]
17. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
[TBL] [Abstract][Full Text] [Related]
18. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
19. GABA transporter-1 inhibitor NO-711 alters the EEG power spectra and enhances non-rapid eye movement sleep during the active phase in mice.
Xu XH; Qiu MH; Dong H; Qu WM; Urade Y; Huang ZL
Eur Neuropsychopharmacol; 2014 Apr; 24(4):585-94. PubMed ID: 24080505
[TBL] [Abstract][Full Text] [Related]
20. Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram.
Wilson SJ; Bailey JE; Rich AS; Adrover M; Potokar J; Nutt DJ
Eur Neuropsychopharmacol; 2004 Oct; 14(5):367-72. PubMed ID: 15336297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
